<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04763499</url>
  </required_header>
  <id_info>
    <org_study_id>1567320</org_study_id>
    <nct_id>NCT04763499</nct_id>
  </id_info>
  <brief_title>The Influence of Daily Strawberry Intake on Vascular Health in Elderly Men</brief_title>
  <official_title>The Influence of Daily Strawberry Intake on Vascular Health in Elderly Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this proposed trial is to examine the vascular protective effects&#xD;
      provided by the daily consumption of 39g of freeze dried strawberry powder (FDSP) for four&#xD;
      weeks. The study population will be older men (60-80 years of age).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed project will determine the influence of short-term FDSP intake on microvascular&#xD;
      function in older men (60-80 years of age). The Framingham reactive hyperemia index (fRHI)&#xD;
      will be used as a measure of microvascular function, and will be measured using peripheral&#xD;
      arterial tonometry (PAT; EndoPAT200). Secondary outcomes will assess circulating levels of&#xD;
      nitrate and nitrite, insulin-like growth factor (IGF), inflammatory cytokines, NADPH oxidase,&#xD;
      platelet aggregation, plasma lipids and blood pressure. This suite of markers will provide&#xD;
      insight on physiological outcomes and risk factors associated with CVD development, and the&#xD;
      metabolic and signaling pathways that influence them. To accomplish the above, after a 4 week&#xD;
      run in period of no powder intake, twenty men (60-80 years of age) will be randomly assigned&#xD;
      to consume 39 g of FDSP or a control powder for four weeks in a randomized, double-blind,&#xD;
      controlled crossover study. This study design will compare the short-term (four week)&#xD;
      response of FDSP intake to an isocaloric control powder that provides no polyphenols, as well&#xD;
      as to their habitual diet where no powder was consumed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>A randomized, double-blind, crossover dietary intervention trial.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>both the control and freeze dried strawberry powders are package with only a code as the identifier</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Framingham Reactive Hyperemia Index (fRHI)</measure>
    <time_frame>4 weeks</time_frame>
    <description>fRHI as a measure of microvascular function will be measured by peripheral arterial tonometry (PAT).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>platelet aggregation</measure>
    <time_frame>4 weeks</time_frame>
    <description>optimal platelet aggregometry using collagen and adp as agonist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Th17 cytokines</measure>
    <time_frame>4 weeks</time_frame>
    <description>TH17 Luminex panel: Interleukin (IL)-1b, IL-4, IL-6, IL-10, IL-17a, IL-21, IL-22, IL-23, IL-31, IL-33, IFNgamma, TNFalpha, IL-17f.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin like growth factor (IGF) and binding proteins (IGFBP)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Luminex panel: IGF-1, -2 and IGFBP 1-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase</measure>
    <time_frame>4 weeks</time_frame>
    <description>soluble form marker of oxidative stress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total nitrate and nitrite</measure>
    <time_frame>4 weeks</time_frame>
    <description>plasma total nitrate and nitrite</description>
  </secondary_outcome>
  <other_outcome>
    <measure>blood pressure</measure>
    <time_frame>4 weeks</time_frame>
    <description>systolic and diastolic blood pressure</description>
  </other_outcome>
  <other_outcome>
    <measure>plasma lipids</measure>
    <time_frame>4 weeks</time_frame>
    <description>clinical lipid panel</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Vascular Dilation</condition>
  <arm_group>
    <arm_group_label>Freeze dried strawberry powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>39g of freeze dried strawberry powder, which represents three daily servings of strawberries.&#xD;
The powder will be mixed in one cup of water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control powder</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>39 g of a powder that matches the sugar and caloric content of the experimental powder. The powder will be mixed in one cup of water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>freeze dried strawberry powder</intervention_name>
    <description>approximately 24 strawberries that have been freeze dried into a powder</description>
    <arm_group_label>Freeze dried strawberry powder</arm_group_label>
    <arm_group_label>control powder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is willing and able to comply with the study protocols.&#xD;
&#xD;
          -  Subject is willing to participate in all study procedures&#xD;
&#xD;
          -  BMI 25.0 - 35 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI ≥ 35 kg/m2&#xD;
&#xD;
          -  Visit 1 Reactive Hyperemia Index (RHI; EndoPAT 2000) ≥ 2.8&#xD;
&#xD;
          -  Dislike or allergy strawberries&#xD;
&#xD;
          -  Self-reported use of daily anticoagulation agents including aspirin, NSAIDs&#xD;
&#xD;
          -  Prescription medications other than on a 6 month self-reported stable dose of&#xD;
             medications for lipid lowering and/or hypertension.&#xD;
&#xD;
          -  Vegan, Vegetarians, food faddists or those consuming a non-traditional diet&#xD;
&#xD;
          -  Fruit consumption ≥ 3 cups/day&#xD;
&#xD;
          -  Regular consumption of strawberries (2-3 servings/week)&#xD;
&#xD;
          -  Vegetable consumption ≥ 4 cups/day&#xD;
&#xD;
          -  Coffee/tea ≥ 3 cups/day&#xD;
&#xD;
          -  Dark chocolate ≥ 3 oz/day&#xD;
&#xD;
          -  Self-reported restriction of physical activity due to a chronic health condition&#xD;
&#xD;
          -  Self-reported chronic/routine high intensity exercise&#xD;
&#xD;
          -  Self-reported diabetes&#xD;
&#xD;
          -  Blood pressure ≥ 140/90 mm Hg&#xD;
&#xD;
          -  Self-reported renal or liver disease&#xD;
&#xD;
          -  Self-reported heart disease, which includes cardiovascular events and stroke&#xD;
&#xD;
          -  Peripheral artery disease Raynaud's syndrome or disease&#xD;
&#xD;
          -  Inability to properly place or wear the PAT probes or abnormal measurements on pre-&#xD;
             screening PAT&#xD;
&#xD;
          -  Abnormal Metabolic or CBC panels (laboratory values outside the reference range) if&#xD;
             determined to be clinically significant by the study physician.&#xD;
&#xD;
          -  Self-reported cancer within past 5 years&#xD;
&#xD;
          -  Self-reported malabsorption&#xD;
&#xD;
          -  Supplement use other than a general formula of vitamins and minerals that meet the RDA&#xD;
&#xD;
          -  Not willing to stop any supplement use, including herbal, plant or botanical, fish&#xD;
             oil, oil supplements a month prior to study enrollment.&#xD;
&#xD;
          -  Indications of substance or alcohol abuse within the last 3 years&#xD;
&#xD;
          -  Cannabis use&#xD;
&#xD;
          -  Current enrollee in a clinical research study.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl L Keen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Nutrition and Internal Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roberta R Holt, PhD</last_name>
    <phone>530-400-5952</phone>
    <email>rrholt@ucdavis.edu</email>
  </overall_contact>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 16, 2021</study_first_submitted>
  <study_first_submitted_qc>February 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>strawberry, diet, vascular function, inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

